AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer
Clinical trial NCT05302336 · UNKNOWN
Trial details
- NCT number
- NCT05302336
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2024-12-30
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.